It’s a rare day that we have a German corporation rather than an American or Chinese one that’s getting its name in fat headlines on business news sites around the world. And this time it’s because of good news in contrast to the recent past. German pharmaceutical and drugs company Bayer has completed its takeover of Monsanto, the US agrichemicals giant, for which Bayer paid €56 billion ($63 billion). It’s the biggest takeover ever undertaken by a German company of a non-German company.
A hated brand disappears
The Monsanto brand has become almost a synonym for corporate evil amongst greenies, with its GMO crop plants (genetically modified organisms) tailor-made to tolerate the company’s herbicide, glyphosate(sold under the trade name Roundup).
Bayer’s takeover of Monsanto predictably generated cries of alarm and outrage by the usual critics of all things capitalist in general and genetic engineering in particular. All these terrible things taken together, they warned, are responsible for the suffering of farmers in developing countries. A monopoly is forming in agrochemicals and GMO crop species that will leave the farmers of the world with no real choices about how to grow their crops if they want to be profitable.
Featured News
EU Extends Support for Farms and Fisheries Amid Market Disruptions
May 5, 2024 by
CPI
Sony and Apollo Bid $26 Billion for Paramount Acquisition
May 5, 2024 by
CPI
Goldman Sachs Resolves Decade-Old Metal-Rigging Class Action Lawsuit
May 5, 2024 by
CPI
Italian Antitrust Ruling Puts Halt on Intesa Sanpaolo’s Fintech Ambitions
May 5, 2024 by
CPI
Google Antitrust Case: Closing Arguments Conclude
May 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI